AZBio Member Spotlight- Darwin Research Group

Based in Scottsdale, Arizona, Darwin Research Group has spent over a decade producing primary intelligence that helps life sciences companies navigate one of the most consequential shifts in modern healthcare: the rise of organized systems of care.

What Healthcare Challenge Is Darwin Research Group Focused on Addressing?

Since 2010, Darwin Research Group has focused on one of the most consequential and least understood challenges in life sciences commercialization: the disconnect between how pharmaceutical companies build their commercial strategies and how organized systems of care govern access to therapies.

Nearly 80 percent of U.S. physicians are employed by health systems or corporate entities. That shift has fundamentally changed who controls access to patients and therapies. Formulary decisions, clinical pathway design, and product adoption are increasingly governed by institutional committees, pharmacy directors, and system executives rather than by individual prescribers. Most life sciences commercial strategies were designed for an environment where physician engagement was the primary lever. That model no longer reflects how access decisions are made.

Darwin produces primary intelligence on health systems, institutions, and decision-makers shaping commercial access, giving life sciences teams the institutional clarity they need to operate effectively in a fundamentally changed market.

How Significant Is This Challenge?

When life sciences companies cannot effectively navigate organized systems of care, therapies that could benefit patients face barriers unrelated to clinical evidence. Formulary exclusions, pathway restrictions, and institutional contracting decisions can prevent effective treatments from reaching the patients who need them, not because the science is insufficient, but because the commercial strategy did not account for how the system governing access works.

Within health systems, pharmacy directors, P&T committee members, and system executives are making increasingly consequential decisions about which therapies are available to their patient populations, often with limited visibility into how manufacturers position their products or the downstream impact of those decisions.

By helping life sciences companies understand institutional decision-making, Darwin supports more informed commercial engagement. That ultimately serves the companies trying to bring innovations to market and the systems trying to make sound clinical and financial decisions on behalf of their patients.

How Is Darwin Research Group’s Work Improving Decision-Making and Healthcare Innovation?

Darwin produces intelligence through direct access to executives, pharmacy leaders, and clinical decision-makers inside organized systems of care. That primary research approach distinguishes Darwin from data vendors, which report on what has already happened, and from consultants, who synthesize secondary sources. Darwin’s intelligence reflects what is happening inside health systems, why it is happening, and what it means for a life sciences company’s commercial position.

The company covers nearly 600 U.S. systems and works with 16 of the top 20 global pharmaceutical companies. Its intelligence products help commercial, market access, and field teams understand the governance structures, gatekeeper relationships, and institutional priorities that determine whether a therapy gains or loses access at a given system.

The result is more targeted commercial engagement, fewer resources deployed against the wrong stakeholders, and better alignment between manufacturer strategy and the operational realities of the systems they are trying to reach.

How Has Being Based in Arizona Supported Darwin Research Group’s Growth?

Scottsdale has been a strong base for Darwin’s growth. Arizona’s life sciences community has expanded significantly over the past decade, and the concentration of health system headquarters, academic medical center affiliates, and bioscience infrastructure in the Phoenix metro area has created natural proximity to the types of organizations and decision-makers Darwin covers.

The state’s business environment has supported Darwin’s ability to recruit and retain a specialized research team, and the broader Arizona bioscience ecosystem has provided opportunities for professional engagement and relationships that would be harder to access in markets with less concentrated life sciences activity. Darwin has grown steadily and is investing in expanding its research network and platform as the intelligence needs of life sciences companies in organized systems of care continue to grow.

What Does the Future Look Like for Darwin Research Group?

Darwin has entered its most significant strategic evolution since its founding. The company is transitioning from a report-based intelligence model to a living intelligence platform: a continuously updated resource covering everything Darwin knows about every organized system it tracks. The goal is to give life sciences commercial teams current, searchable intelligence rather than periodic roadmaps, structured to serve corporate strategy teams and field-based account managers preparing for individual system engagements.

Darwin is also expanding its research network, deepening its panel of health system executives and clinical leaders across new specialties and system types, and preparing to serve medical device and non-pharmaceutical life sciences clients who face similar challenges navigating organized systems of care.

Health system consolidation is accelerating. Physician employment is expanding. Institutional governance over clinical and formulary decisions is deepening. The need for the intelligence Darwin produces will only grow, and the company is investing accordingly.

“I’m motivated to do this work every day because health care is complex and always evolving — even after 30 years in the industry, I’m still learning something new. But the bigger picture, for me, is about improving the care people receive: helping people live longer and with a better quality of life.